Desensitisation to subcutaneous insulin using CSII followed by i-Port Advance™

Rob Gregory, Dawn Ackroyd, Hamidreza Mani, Alexandra Croom

Full Text:

HTML PDF

References


 Moyes V, Driver R, Croom A, Mirakian,R, Chowdhury TA. Insulin allergy in a patient with type 2 diabetes successfully treated with continuous subcutaneous insulin infusion. Diabet Med 2006;23:204-06. https://doi.org/10.1111/j.1464-5491.2006.01811.x

 Vervloet D, Pradal M, Birnbaum J, Koeppel M-C. Drug Allergy. Fourth Edition. Phadia AB, 2009, 322-4. http://www.phadia.com/PageFiles/ 27357/Drug-Book-web.pdf

 Nagai T, Nagai Y, Tomizawa T, Mori M. Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion. Intern Med 1997;36:575-8. https://doi.org/10.2169/internalmedicine.36.575

 Pratt EJ, Miles P, Kerr D. Localized insulin allergy treated with continuous subcutaneous insulin. Diabet Med 2001;18:515-16. https://doi.org/10.1046/j.1464-5491.2001.00454-2.x

 Sola-Gazagnes A, Pecquet C, Radermecker R, et al. Successful treatment of insulin allergy in a type 1 diabetic patient by means of constant subcutaneous pump infusion of insulin. Diabetes Care 2003;26:2961-2. https://doi.org/10.2337/diacare.26.10.2961

 Fujikawa T, Imbe H, Date M, Go Y, Kitaoka H. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion. Diabetes Res Clin Pract 2012;97:e31-3. https://doi.org/10.1016/j.diabres.2012.04.027




DOI: http://dx.doi.org/10.15277/bjd.2017.116

Refbacks

  • There are currently no refbacks.


The Journal of the Association of British Clinical Diabetologists